Car t cells

Bexalta --- mfr

The CAR technologies currently in development for hematologic cancers are a form
of adoptive cell therapy in which the patients T cells are cultured and then primed to
specifically recognize CD19, a protein expressed on normal and malignant cells of B-

cell lineage. Thus, CD19 presents a suitable tumor-associated antigen against which
to target anticancer agents (Figure).
The experimental technology has been successfully used to combat acute
lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), and non-Hodgkin
lymphoma, bringing many patients who participated in clinical trials into complete
remission (Table). The success of these therapies has caused much excitement, and
hopes are high that the CAR approach could one day become a frontline treatment
for many types of cancer, including solid tumors such as breast, ovarian, and
prostate cancers. - See more at: http://www.onclive.com/publications/oncologylive/2014/november-2014/bringing-cars-to-market-novel-t-cell-therapies-makerapid-progress-despite-challenges/1#sthash.n2eRHgDl.dpuf

Cfg 166 deafness

Cardio metabolic--- opththa
Be non myopic --- tradeoffs on curative treatment..

Plst 1.84
--- clbs

Caladrius Biosciences is an American biopharmaceutical company active in the field of stem cell therapy
and regenerative medicine, particularly of cardiovascular disease. Wikipedia

Investigational New Drug (IND) Application

2:45pm 3:00pm
3:00pm 3:15pm

AGTCAGTC is developing cures for rare

lung and eye diseases, offering hope to
patients with unmet medical needs

Oxford BioMedica
ReNeuron

3:15pm 3:30pm

Cell Therapy Ltd.

34 20 min

35

BALLROOM 2

BioLife Solutions

4:15pm 4:30pmMaxCyte

Terumo

MaxCyte

BCT

4:30pm 4:45pm

MaxCyte

4:45pm 5:00pm

TaiwanBio

5:00pm 5:15pm

BrainStor
m Cell
Therapeut
ics

5:15pm 5:30pm

GenVec

5:30pm 5:45pm

REGENXB
IO
Avita
Medical

5:45pm 6:00pm

DAY 2

Data & Safety Monitoring Boards (DSMBs)

http://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CBER/

Uniqure is ffunded -----